Following his defeat to Floyd Mayweather Jr., Manny Pacquiao revealed that he fought with a bum right shoulder.
Turns out it’s more serious than expected.
On Monday night, Los Angeles orthopedic surgeon Dr. Neal ElAttrache told ESPN that Pacquiao has a “significant tear” that requires surgery and will be out nine to 12 months.
The
injury, Pacquiao and trainer Freddie Roach said Saturday, affected the
ability to throw his patented right hook. Roach said he even considered
postponing the bout after learning of the injury approximately 2 1/2
weeks prior to fight night.
In a joint statement released earlier Monday, Pacquiao and Top Rank elaborated on the injury:
“Manny
went to see world-class doctors, partners in the prestigious Kerlan
Jobe Orthopedic Clinic, who performed tests and, in consultation with
Manny, his promoter, and his advisors, concluded that with short rest,
treatments, and close monitoring, Manny could train and, on May 2, step
into the ring against Floyd Mayweather.”
After consulting with
doctors, Pacquiao’s team decided on Toradol, a non-steroidal
anti-inflammatory, as pre-fight treatment. Pacquiao’s advisors then
contacted the United States Anti-Doping Agency (USADA), the group
responsible for overseeing agreed upon random drug testing. After
speaking with Pacquiao’s doctors twice and investigating, USADA approved
the proposed treatment (for training and fight night) in writing.
“Manny
continued to train and his shoulder improved, though not 100 percent. …
in consultation with his doctors, promoter and advisors, Manny decided
to proceed with the fight anticipating that he could receive his
pre-fight treatment.”
However,
USADA doesn’t oversee the regulation of fights and is not a governing
body. The group simply approved the treatment for the purposes of drug
testing.
When the Nevada
State Athletic Commission administered the pre-fight examination Friday
afternoon, they gave Pacquiao a questionnaire. Question No. 6 asked if
he had “any injuries to your shoulders, elbows or hands that require
examination,” and the fighter checked “no,” the commission’s executive
director Bob Bennett told USA TODAY Sports on Monday.
In
fact, Bennett says the commission wasn’t aware of any injury until
Pacquiao’s team asked for the Toradol injection (as well as Lidocaine, a
numbing agent) at approximately 6:08 p.m. PT on fight night.
According
to Bennett, Top Rank then alleged that USADA had provided documentation
that informed the commission of the shoulder injury, but he says they
never received such information. Bennett says he contacted USADA sport
testing and resources director Andy Morrison to ask if any emails were
sent regarding the injury, and Morrison said he hadn’t.
The
commission then interviewed Pacquiao’s physicians who advised that his
health and safety would not be at risk if he fought without the
injection. Manny then assured the commission that his shoulder “felt
fine and strong, and it was not bothering him and that he was ready to
fight,” per Bennett.
Pacquiao
was also interviewed by the commission’s physicians at the Friday
weigh-in and informed them of no problems with his shoulders. According
to the record, his “strength appeared equal in both arms and he had full
range of motion in his shoulders.” That information in addition to his
denial of a shoulder injury on the questionnaire led the commission to
disallow the injections.
© Provided by USA Today Sports
Manny Pacquiao (left) punches Floyd Mayweather against the ropes during
their boxing bout at the MGM Grand Garden Arena. (Mark J. Rebilas, USA
TODAY Sports)
Top Rank maintains that “USADA
had provided a copy of its contract with the fighters to the
commission.” Could the commission have just allowed him to take the
injection once they found out Saturday night and taken Pacquiao at his
word without any MRI results?
“If
we had information when Top Rank knew about Manny’s shoulder injury,
and they brought that to our attention, then we obviously would have
worked something out. But the drugs that Manny wanted to inject himself
with were not PEDs. They’re not on the WADA panel. There’s no TUE
(therapeutic use exemption) required. So it’s not an issue, in all
fairness, to USADA. For whatever reason Top Rank, at that point in time,
didn’t think it behooved them to notify us of Manny’s injury.”
No comments:
Post a Comment